Fact CheckerSign in

NCT07903805Recruiting

Asthma and Primary Arterial Hypertension: an Inflammatory Link?

Source: ClinicalTrials.gov · Last updated 30 Oct 2026

Brief summary (registry, in English)

A low-intervention, prospective, experimental study will be conducted with the overall aim of assessing the inflammatory, functional and clinical differences between patients with asthma and those with asthma and hypertension, in order to improve our understanding of asthma and its comorbidities

Status (registry)
Recruiting
Study type
Observational
Enrollment
74 (estimated)
First submitted
23 Oct 2026
Start date
23 Dec 2023
Primary completion date
31 Dec 2028
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
NCT number
NCT07903805

What you commit to

  • Study type: Observational
  • Planned participants: 74
  • From 23 Dec 2023 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of asthma exacerbation requiring changing of pharmacological treatment in the previous month.
  • Diagnosis of concomitant Chronic Obstructive Pulmonary Disease (COPD); Obstructive Sleep Apnoea Syndrome (OSA); Clinically significant bronchiectasis; Allergic bronchopulmonary aspergillosis (ABPA); Atopic dermatitis;
  • Diagnosis of concomitant Autoimmune Diseases; History of Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), or (Hepatitis C Virus)HCV ;

Other illness

  • Active significant infection
  • Malignancy, current or within the past 5 years. Suspected malignancy or undefined neoplasms;
  • Cognitive impairment;
  • History of clinically significant chronic heart diseases;

Other

  • Active smoking status or ex-smoker with Pack/Year major than 10;
  • BMI major than 30 Kg/m2;
  • Pregnancy;

Who the study is looking for

  • Age ≥18 and ≤85 years;
  • Diagnosis of moderate/severe asthma according to current Global Initiative for Asthma (GINA) guidelines
  • Diagnosis of moderate/severe asthma according to current GINA guidelines and primary arterial hypertension according to current European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines
  • Patients able to collaborate in the required procedures;
  • Signed informed consent.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCSS ICS Maugeri Tradate
Coordinator of this site? Confirm its status
TradateItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.